Prot# IM103008: Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression Trial (BENEFIT)

  • Abecassis, Michael Messod (Co-PD/PI)
  • Baker, Talia Barzel (Co-PD/PI)
  • Friedewald, John J (Co-PD/PI)
  • Fryer, Jonathan Paul (Co-PD/PI)
  • Gallon, Lorenzo (Co-PD/PI)
  • Leventhal, Joseph R (Co-PD/PI)
  • Luo, Xunrong (Co-PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/2/069/24/10

Funding

  • ICON Clinical Research, LLC (IM103008/BENEFIT // IM103008/BENEFIT)
  • Bristol-Myers Squibb Company (IM103008/BENEFIT // IM103008/BENEFIT)